|
|
Article: Research from Mississippi State University, College of Veterinary Medicine reveals new findings on drug resistance.
- Article from:
- Cancer Weekly
- Article date:
- July 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data detailed in 'Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition' have been presented. According to recent research from the United States, "Immunoconjugates of epirubicin were synthesized with monoclonal antibodies against the epidermal growth factor receptors, HER2/neu and EGFR, by creating a sulfhydryl-reactive epirubicin intermediate applying heterobifunctional succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC), which was introduced at alpha-monoamide groups of the epirubicin carbohydrate moiety. In parallel, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Underdogs with a bite: Mississippi State; Syracuse ...
The Washington Times;
March 29, 1996 ;
700+ words
... ... The Syracuse Orangemen and Mississippi State Bulldogs have made a season ... Georgetown and Villanova. And Mississippi State's Southeastern Conference ... Syracuse and fifth-seeded Mississippi State. The two will meet tomorrow ...
|
|